Search Results - "Burstein, Harold J"

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

A look at current and potential treatment approaches for hormone receptor‐positive, HER2‐negative early breast cancer.

Authors: Harbeck, Nadia Burstein, Harold J. Hurvitz, Sara A. et al.

Source: Cancer (0008543X). Jun2022 Supplement S11, Vol. 128, p2209-2223. 15p.

Preoperative Therapy as a Model for Translational Research in Breast Cancer.

Authors: Burstein, Harold J.¹ (AUTHOR)

Source: Cancer Investigation. May2008, Vol. 26 Issue 3, p217-221. 5p. 3 Charts.

Now or later? Switching therapies in metastatic breast cancer.

Authors: Valenza, Carmine Regan, Meredith M Burstein, Harold J

Source: Lancet Oncology. Aug2026, Vol. 27 Issue 8, p904-906. 3p.

Systemic Therapy for Estrogen Receptor-Positive, HER2-Negative Breast Cancer.

Authors: Longo, Dan L. Burstein, Harold J

Source: New England Journal of Medicine. 12/24/2020, Vol. 383 Issue 26, p2557-2570. 14p.

I mmunotherapy for Early-Stage Triple-Negative Breast Cancer.

Authors: Burstein, Harold J.¹

Source: New England Journal of Medicine. 11/28/2024, Vol. 391 Issue 21, p2048-2049. 2p.

Adjuvant Capecitabine in Triple-Negative Breast Cancer: New Strategies for Tailoring Treatment Recommendations.

Authors: Parsons, Heather A. Burstein, Harold J.

Source: JAMA: Journal of the American Medical Association. 1/5/2021, Vol. 325 Issue 1, p36-38. 3p.

Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast cancer

Authors: Burstein, Harold J. Bellon, Jennifer R. Galper, Sharon et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Feb2006, Vol. 64 Issue 2, p496-504. 9p.

Subjects: Breast cancer, Radiotherapy, Drug therapy, Doxorubicin, Research

Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update.

Authors: Burstein, Harold J. Lacchetti, Christina Griggs, Jennifer J.

Source: Journal of Oncology Practice. Feb2019, Vol. 15 Issue 2, p106-107. 3p.

Update in Hematology and Oncology: Evidence Published in 2015.

Authors: Ma, Alice D Burstein, Harold J

Source: Annals of Internal Medicine. 5/3/2016, Vol. 164 Issue 9, pW32-W36. 5p.

Adjuvant Endocrine Therapy for Women With Hormone Receptor--Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression Summary.

Authors: Burstein, Harold J. Lacchetti, Christina Griggs, Jennifer J.

Source: Journal of Oncology Practice. Apr2016, Vol. 12 Issue 4, p390-393. 5p.

Trastuzumab: qui bono?

Authors: Krop, Ian E Burstein, Harold J

Source: JNCI: Journal of the National Cancer Institute. Dec2013, Vol. 105 Issue 23, p1772-1775. 4p.

Radiation therapy for ductal carcinoma in situ.

Authors: Punglia, Rinaa S. Burstein, Harold J. Weeks, Jane C.

Source: Cancer (0008543X). Feb2012, Vol. 118 Issue 3, p603-611. 9p.

American Society of Clinical Oncology Clinical Practice Guideline Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor -- Positive Breast Cancer.

Authors: Burstein, Harold J. Griggs, Jennifer J. Prestrud, Ann A. et al.

Source: Journal of Oncology Practice. Sep2010, Vol. 6 Issue 5, p243-246. 4p. 2 Charts.

Case 25-2009.

Authors: Burstein, Harold J. Souter, Irene D'Alessandro, Helen Anne et al.

Source: New England Journal of Medicine. 8/13/2009, Vol. 361 Issue 7, p699-707. 9p. 2 Diagrams.

Pharmacogenomic Variation of CYP2D6 and the Choice of Optimal Adjuvant Endocrine Therapy for Postmenopausal Breast Cancer: A Modeling Analysis.

Authors: Punglia, Rinaa S. Burstein, Harold J. Winer, Eric P. et al.

Source: JNCI: Journal of the National Cancer Institute. 5/7/2008, Vol. 100 Issue 9, p642-648. 7p. 3 Charts, 2 Graphs.

Trastuzumab Plus Vinorelbine or Taxane Chemotherapy for HER2-overexpressing Metastatic Breast Cancer: The Trastuzumab and Vinorelbine or Taxane Study.

Authors: Burstein, Harold J. Keshaviah, Aparna Baron, Ari D. et al.

Source: Cancer (0008543X). Sep2007, Vol. 110 Issue 5, p965-972. 8p. 4 Charts, 2 Graphs.

Side Effects of Chemotherapy and Combined Chemohormonal Therapy in Women With Early-Stage Breast Cancer.

Authors: Partridge, Ann H. Burstein, Harold J. Winer, Eric P.

Source: JNCI: Journal of the National Cancer Institute. 2001, Vol. 93 Issue 30, p135. 8p. 3 Charts.

New Combinations with Herceptin[sup ®] in Metastatic Breast Cancer.

Authors: Winer, Eric P. Burstein, Harold J.

Source: Oncology. 2001 Supplement 2, Vol. 61, p50-57. 8p.